🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

18,54 USD

Máx. histórico

178,74

2142 días

Split 1:6 del 12/07/2012

Caída desde máximo

-89,63%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,20%

Cierre anterior

18,32

Rango de hoy

18,29 – 18,81

Volumen hoy

1.397.929

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,44%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 23 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
06/06/2001 55,62 55,80 53,70 53,70 -2,72% 3,78% 21.400
05/06/2001 52,14 55,80 52,14 55,20 +6,36% 7,02% 32.467
04/06/2001 51,00 52,68 51,00 51,90 +2,00% 3,29% 14.833
01/06/2001 49,74 51,30 48,90 50,88 +0,47% 4,83% 16.900
31/05/2001 49,50 51,00 47,40 50,64 +1,81% 7,27% 25.717
30/05/2001 48,00 51,18 46,50 49,74 -0,72% 9,75% 31.367
29/05/2001 48,66 50,88 48,00 50,10 -1,76% 5,92% 25.133
25/05/2001 50,10 51,12 46,62 51,00 +1,80% 8,98% 45.833
24/05/2001 56,94 57,00 48,60 50,10 -11,08% 14,75% 68.617
23/05/2001 61,08 61,14 52,98 56,34 +8,55% 13,36% 242.683
22/05/2001 49,50 51,90 48,66 51,90 +9,08% 6,55% 55.467
21/05/2001 43,50 48,60 43,44 47,58 +10,14% 11,86% 59.767
18/05/2001 40,80 43,50 40,56 43,20 +6,67% 7,21% 20.000
17/05/2001 42,00 43,50 40,44 40,50 -3,98% 7,29% 27.750
16/05/2001 39,36 42,18 38,10 42,18 +6,52% 10,37% 22.283
15/05/2001 39,84 39,90 39,06 39,60 +0,00% 2,11% 8.950
14/05/2001 40,50 40,50 39,18 39,60 -2,22% 3,26% 7.000
11/05/2001 40,44 40,50 38,70 40,50 +0,15% 4,45% 18.133
10/05/2001 40,98 41,58 39,00 40,44 -1,32% 6,30% 16.400
09/05/2001 39,06 42,60 38,40 40,98 -1,44% 10,75% 30.133
08/05/2001 42,60 42,60 39,60 41,58 -2,39% 7,04% 15.750
07/05/2001 44,16 44,40 42,60 42,60 -2,20% 4,08% 15.450
04/05/2001 38,70 43,56 38,04 43,56 +11,69% 14,26% 22.617
03/05/2001 39,36 39,90 37,50 39,00 -0,76% 6,10% 11.767
02/05/2001 41,94 42,00 39,00 39,30 -4,52% 7,15% 16.250
01/05/2001 42,00 42,18 37,80 41,16 +0,29% 10,43% 31.367
30/04/2001 38,40 41,10 38,28 41,04 +8,74% 7,34% 39.517
27/04/2001 36,30 38,04 35,70 37,74 +4,83% 6,45% 26.617
26/04/2001 35,94 36,96 35,70 36,00 +0,67% 3,51% 25.617
25/04/2001 35,10 36,00 35,10 35,76 +1,88% 2,56% 16.683